Clinical Trials Browser

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00513071 2018-04-19

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

28 enrolled 9 charts

Genitourinary

Prostatic Neoplasms

NCT02085603 2018-04-13

SarCaBon

Phase 2 Completed

12 enrolled

Tumor-Agnostic

Neoplasms

NCT02116712 2016-11-30

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Phase 1 Completed

9 enrolled

Lymphangioleiomyomatosis

NCT01196741 2015-05-05

SaPPrOC

Phase 2/3 Completed

107 enrolled 17 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00669019 2014-05-21

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

23 enrolled 6 charts

Dermatologic

Melanoma

NCT00513435 2014-04-30

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

9 enrolled 8 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT00559507 2014-04-30

Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery

Phase 2 Completed

12 enrolled 8 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00704366 2011-05-16

AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours

Phase 1 Completed

18 enrolled

Other solid neoplasm

Solid Tumor

NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Phase 1 Completed

40 enrolled

BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell